Seelos Therapeutics, Inc. Proceeds from Other Equity
Seelos Therapeutics, Inc. reported Proceeds from Other Equity of $500.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2023-03-10
- Seelos Therapeutics, Inc. proceeds from other equity for fiscal 2022 was $500.00K.
| Period end | Proceeds from Other Equity 12 month |
|---|---|
| 2022-12-31 | $500.00K 10-K · filed 2023-03-10 |